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Abstract The dynamic assembly/disassembly of non-muscle
myosin II filaments is critical for the regulation of enzymatic
activities and localization. Phosphorylation of three threonines,
1823, 1833 and 2029, in the tail of Dictyostelium discoideum
myosin II has been implicated in control of myosin filament
assembly. By systematically replacing the three threonines to
aspartates, mimicking a phosphorylated residue, we found that
position 1823 is the most critical one for the regulation of myosin
filament formation and in vivo function. Surprisingly, a single
charge change is able to perturb filament formation and in vivo
function of myosin II.
z 2000 Federation of European Biochemical Societies.
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1. Introduction
In non-muscle cells, active reorganization of myosin II (re-
ferred from this point forth simply as myosin) ¢laments is
essential to a number of processes that take place at distinct
locations in the cell. Most dramatically, myosin localizes to
the cleavage furrow during cell division [1,2] and has been
shown to be essential for cytokinesis in suspension and on a
non-adhesive surface [3^5]. Although the cellular function of
myosin is completely dependent on its ability to assemble into
¢laments [6], little is known about the speci¢c features of the
myosin tail that allow formation of bipolar ¢laments.
The myosin tail is comprised almost entirely of heptad re-
peats common to all coiled-coil forming regions, with the
residues at the ¢rst and the fourth position packed in the
hydrophobic core of the coil [7]. Superimposed on this basic
structure, the tail displays alternating regions of positively and
negatively charged residues. These regions are thought to be
important to intermolecular interactions that form the basis of
¢lament assembly as well as to inter- and intramolecular in-
teractions that favor ¢lament disassembly [8].
The cellular slime mold, Dictyostelium discoideum, has pro-
ven to be particularly amenable to detailed studies of both the
in vivo as well as biochemical properties of myosin function.
Analysis of Dictyostelium myosin tail fragments has identi¢ed
two regions at the C-terminal end of the tail that account for
the assembly and disassembly properties of the intact mole-
cule. The ¢rst region (Fig. 1, hatched) comprises a 34 kDa
segment that is both necessary and su⁄cient for self-assembly
in vitro [9]. The second region, located immediately C-termi-
nal to the assembly domain, serves to mediate interactions
within the tail and thus the assembly state of myosin. Three
threonines within this region have been shown to be targets of
two speci¢c myosin heavy chain kinases [10,11]. Phosphory-
lation of these residues results in the inhibition of ¢lament
formation at physiological salt concentrations [12,13].
These observations have been supported by site-speci¢c mu-
tagenesis studies targeting these three threonines, located at
amino acid positions 1823, 1833 and 2029 [6]. Substitution of
all three of these threonines to alanines prevents phosphory-
lation at those sites. This results in a myosin that constitu-
tively forms thick ¢laments and thus is found almost exclu-
sively in a Triton-insoluble cytoskeletal pellet [6]. Substitution
of these threonines to aspartates was also studied to simulate
a permanently phosphorylated state. These substitutions result
in the inhibition of ¢lament assembly similar to that observed
with phosphorylated myosin and failure of this mutant myo-
sin to localize to the Triton-insoluble pellet. Moreover, unlike
the triple alanine myosin, the triple aspartate myosin is unable
to rescue myosin null cells for cytokinesis in suspension and
development into fruiting bodies [6].
These studies demonstrate the importance of phosphoryla-
tion within this region of the tail in regulating myosin func-
tion. However, whether such regulation requires phosphory-
lation of all three threonines remains unclear. To monitor the
in£uence of phosphorylation at each of these three threonines
on the assembly and disassembly properties as well as the in
vivo function of myosin, we have systematically mutated these
three threonines at amino acid positions 1823, 1833 and 2029
to aspartates in all six possible combinations. These proteins
are denoted as DTT, DDT, DTD, TDT, TDD and TTD (see
Section 2). Analyses of these mutant myosins both in vitro
and in vivo suggest that phosphorylation of threonine 1823
critically determines the regulation of myosin ¢lament forma-
tion and that the inability to remove the negative charge at
this position completely disrupts in vivo function.
2. Materials and methods
2.1. Plasmid construction
All DNA manipulations were carried out using standard methods
[14]. Expression plasmids encoding the myosin tail variants T1823D,
(pLittleDTT); T1823D, T1833D (pLittleDDT); T1823D, T2029D
(pLittleDTD); T1833D (pLittleTDT); T1833D, T2029D (pLit-
tleTDD); T2029D (pLittleTTD) and T1823A, T1833D, T2019D
(pLittleADD) were based on the vector pLittleMyo which contains
the wild-type (wt) Dictyostelium mhcA gene inserted into pLittle, an
extrachromosomally replicating expression vector [15]. In brief, the
vector pBIGAsp [16] was digested with BglII and SmaI. The obtained
fragment, containing most of the mhcA gene, was ligated with pBlue-
script II SK(+) (Stratagene, La Jolla, CA, USA) linearized with SmaI
and BamHI. This plasmid pBlueMyo was used to construct the tail
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variants described above by using polymerase chain reaction (PCR)-
based mutagenesis (Quickchange1, Stratagene, La Jolla, CA). The
PCR products were sequenced to con¢rm the presence of the desired
point mutations. pBlueMyo containing the mutated gene fragments
was digested with KpnI and the fragment containing the myosin cod-
ing sequence cloned in pLittlevKK (pLittleMyo digested with KpnI
and religated without insert). The right orientation of the insert was
checked by digesting the plasmids with HindIII.
2.2. Cell culture
HS1, a myosin null cell line [17], was transformed with wt-myosin
(pBIGMyo) and DDD-myosin (pBIGAsp), and the plasmids encoding
the di¡erent myosin tail variants using standard electroporation con-
ditions [18]. Individual clones were grown at 21‡C in HL5 media [19],
supplemented with Pen-Strep (60 U/ml of penicillin, 60 Wg/ml strepto-
mycin) and 10 mg/ml G418 (Geneticin; Life Technologies, Gaithers-
burg, MD, USA) on plastic dishes or in suspension. To observe de-
velopment, cells were spotted onto Klebsiella aerogenes lawns on SM
agar plates [19].
2.3. Protein puri¢cation
Myosin and its variants were puri¢ed from stably transformed Dic-
tyostelium cells grown in suspension (variants TDD-, TTD-, TDT-,
ADD- and wt-myosin) or on plastic Petri dishes (variants DDD-,
DDT-, DTT-, DTD-myosin). Proteins were typically puri¢ed from
30 g of cells. Puri¢cation was performed essentially as described by
[17] with the following modi¢cations. The washed cell pellet was re-
suspended in 9 vol./g cells of cold lysis bu¡er (25 mM HEPES pH 7.4,
50 mM NaCl, 2 mM EDTA, 1 mM DTT, 1 mM phenylmethylsul-
fonyl £uoride, 0.2 mM TPCK, 0.2 mM TLCK and 0.5% Triton X-
100). The cell suspension was gently stirred on ice for 10 min and the
actomyosin precipitate was collected by centrifugation at 20 000Ug
for 30 min. The pellet was resuspended in 3 vol./g cells of 10 mM
HEPES pH 7.4, 150 mM NaCl, 2 mM EDTA, 1 mM DTT and the
suspension was than diluted with 6 vol./g cells of 10 mM HEPES pH
7.4, 2 mM EDTA, 1 mM DTT. The suspension was incubated on ice
for 10 min. The actomyosin precipitate was collected by another cen-
trifugation step. Extraction of the myosin was achieved by resuspend-
ing the actomyosin pellet in 4 vol./g cells of bu¡er containing 10 mM
HEPES pH 7.4, 300 mM NaCl, 3 mM MgCl2, 2 mM ATP and 1 mM
DTT. The solution was centrifuged at 18 000Ug and the supernatant
was collected. RNase A (50 Wg/ml) was added and the solution was
concentrated by dialyzing against Aquacode III (Calbiochem, La Jol-
la, CA, USA) solution in 10 mM HEPES pH 7.4, 150 mM NaCl,
4 mM MgCl2, 1 mM DTT. The concentrated dialysate was adjusted
to 2 mM ATP and immediately centrifuged at 50 000Ug for 20 min.
The supernatant was diluted with 2 vol. of 10 mM HEPES pH 7.4,
200 mM NaCl, 40 mM NaPPi, 1.2 M KI and immediately loaded on a
gel ¢ltration column (Bio-Gel A-15m, 100^200 mesh, Bio-Rad, Rich-
mond, CA, USA) previously equilibrated with 10 mM HEPES pH
7.4, 200 mM NaCl, 20 mM NaPPi, 0.6 M KI. The concentration of
protein was determined using the Bradford assay [20], with rabbit
skeletal myosin as the standard.
2.4. Electrophoresis and immunoblots
Equal amounts of Dictyostelium whole cell lysates were loaded onto
two sodium dodecyl sulfate/7.5% polyacrylamide gels. These gels were
either stained with Coomassie brilliant blue or transferred onto nitro-
cellulose paper. The blot was probed with My6, an anti-Dictyostelium
myosin II monoclonal antibody, followed by an appropriate second-
ary antibody conjugated to horseradish peroxidase (Bio-Rad, Rich-
mond, CA, USA). An enhanced chemiluminescence system (Amer-
sham, La Jolla, CA, USA) was used to visualize the signals.
2.5. 4,6-Diamidino-2-phenylindole (DAPI) staining
Cells expressing the di¡erent myosin variants were ¢xed and stained
with DAPI, as described previously [19].
2.6. Salt-dependence ¢lament assay
Myosin assembly was analyzed using a ¢lament sedimentation as-
say [22] modi¢ed by [23]. Aliquots (100 Wl) of puri¢ed myosin (0.2 mg/
ml) were mixed with an equal volume of two times concentrated KCl
solutions in TL 100.1 polycarbonate tubes. After a 15 min incubation
on ice, assembled myosin was sedimented at 55 000 rpm in a TLA
100.1 rotor for 10 min at 4‡C. The supernatant fractions containing
monomeric myosin were analyzed with the Bradford assay [20]. The
fraction soluble was calculated by dividing the amount of protein in
the supernatant by the total protein.
2.7. Cell imaging
Cells were imaged with a Zeiss Axiovert 100 microscope and a
1.6U Optovar lens (Zeiss, Thornwood, NY, USA). Images were col-
lected on a cooled charge-coupled device camera as described [2].
3. Results
3.1. Expression of mutant MHC genes in Dictyostelium
To examine the relative importance of the three threonine
residues, 1823, 1833 and 2029, of the Dictyostelium myosin
tail in regulation of myosin thick ¢lament formation and my-
osin function in vivo, we constructed plasmids that express all
six possible combinations of aspartates and threonines at the
positions 1823, 1833 and 2029. Furthermore, we constructed a
plasmid encoding a myosin heavy chain in which threonine
1823 was replaced by an alanine and threonines 1833 and
2029 were changed to aspartates. Transformation of the my-
osin null cell line HS1 with the plasmids pLittleDTT, pLit-
tleDDT, pLittleDTD, pLittleTDD, pLittleTTD, pLittleTDT,
pLittleADD as well as pLittleMyo and pBigAsp resulted in
cells that express DTT-myosin, DDT-myosin, DTD-myosin,
TDD-myosin, TTD-myosin, TDT-myosin, ADD-myosin, wt-
myosin and DDD-myosin, respectively. The expression level
Fig. 1. Schematic representation of functional domains within the tail of Dictyostelium myosin.
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of all the myosin variants was comparable to wt-myosin in wt
cells as seen by Western blot analysis (data not shown).
3.2. Cytokinesis
To assay competence for myosin-dependent cytokinesis in
suspension, we placed transformants of all myosin variants in
suspension culture and monitored their growth. Cells express-
ing wt-myosin grew in suspension with a doubling time of
approximately 10^15 h, but sometimes slower (Fig. 2). Unlike
cells growing on plates, where all the cell lines were able to
grow by myosin-independent cytokinesis [4,21], cells express-
ing myosin variants in which threonine 1823 was replaced by
an aspartate could not survive in suspension. However, re-
placement of aspartate 1823 with alanine in the ADD-myosin
variant recovered the ability of the cells to grow in suspension.
From these studies, we suggest that threonine at position 1823
is a critical phosphorylation site for regulation of myosin as-
sembly/disassembly and function in vivo.
We then investigated the shape and size of the di¡erent
transformants in suspension by video microscopy. All the
cell lines transformed with a plasmid encoding a myosin var-
iant with a wt-threonine or an alanine at position 1823 be-
haved like wt cells, in that they appeared generally round and
actively extended and retracted projections (pseudopodia and
¢lopodia). All transformants expressing myosin variants with
position 1823 replaced by an aspartate were increased in size
like myosin null cells [3]. They were capable of extending and
retracting ¢lopodia and lamellipodia and of forming streams
that led to aggregates. These cells also ingested bacteria by
phagocytosis, but at a lower rate than the wt cells.
Mutant cells that had been grown in suspension were plated
onto coverslips, ¢xed and stained with the DNA stain, DAPI.
Immunomicroscopy of stained cells showed that all constructs
with an aspartate at position 1823 of the myosin heavy chain
lead to the formation of large multinucleated cells in suspen-
sion, which is consistent with abnormalities in the cell division
process (Fig. 3). In contrast, all cells containing a threonine or
an alanine at position 1823 were mostly single nucleated like
wt cells. The presence or absence of a negative charge at
positions 1833 and 2029 seemed to have only a slight in£uence
on the formation of multinucleated cells (Fig. 3) or on growth
in suspension (Fig. 2). These results are consistent with threo-
nine 1823 being the most critical site for regulation of thick
Fig. 2. Growth curves of Dictyostelium cells expressing di¡erent my-
osin heavy chain variants. At time point 0 h, 200 Wl aliquots of cells
grown on plates were placed into 20 ml suspension culture. Cells
transformed with pLittleDTD (R), pLittleDDT (F), pLittleDTT
(S), pLittleTDD (E), pLittleTTD (P), pLittleTDT (O), pLit-
tleADD (7), pLittleMyo (a) and pBigAsp (b).
Fig. 3. Quantitative analysis of the number of nuclei in wt-myosin, TDD-myosin, TDT-myosin, TTD-myosin, ADD-myosin, DDD-myosin,
DTT-myosin, DTD-myosin and DDT-myosin expressing cells. Cells grown for 10 generations in shaking culture were plated on glass coverslips
for 15 min before methanol ¢xation and nuclei staining with DAPI. From each transformed cell line, 200 cells were counted.
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¢lament formation and myosin function in vivo. The majority
of the D1823 containing myosin heavy chain variants was
between three and four nuclei. Furthermore, since between
10 and 20% of these cells contain more than ¢ve nuclei, it
would appear that although mutant cells proceed to an ad-
vanced stage in mitosis, they do not complete cytokinesis.
This phenomenon was already described for the DDD-myosin
variant [6]. The defect in cytokinesis was apparently corrected
for when large, multinucleated cells grown in suspension were
transferred to a surface, after which their average size and
number of nuclei decreased in a short period of time by the
myosin-independent cytokinesis B [5,33].
3.3. Developmental properties
Myosin null cells are unable to complete development
[3,4,21]. Transformation of plasmids that express myosin wt
heavy chain complement this defect. In contrast, the DDD-
myosin variant is not able to rescue development [6]. On bac-
terial lawns, DDD-myosin expressing cells were unable to
form sorocarps and arrested at the mound stage. To test the
ability of our myosin heavy chain variants to complement this
developmental defect, we transformed myosin null cells with
the corresponding plasmids and plated them on bacterial
lawns. Cells complemented with wt-myosin, TTD-myosin,
TDT-myosin, TDD-myosin and ADD-myosin aggregated
and formed sorocarps on Klebsiella lawns within 4^5 days
(Fig. 4). Transformation with pLittleDTT or pLittleDTD al-
lowed the cells to aggregate and form short ¢ngers mostly,
and further development occurred only rarely (e.g. in Fig. 4,
DTD has passed the sporulation stage). The myosin heavy
chain variants DDD-myosin and DDT-myosin were arrested
at the mound stage, like myosin null cells (Fig. 4). All of the
above in vivo tests suggest that threonine 1823 is the most
critical site for regulation of myosin thick ¢lament formation.
3.4. Biochemical characterization of puri¢ed myosin heavy
chain variants
Filament formation of Dictyostelium myosin in vitro is
highly dependent upon ionic strength [24]. wt-Myosin has its
greatest solubility in bu¡ers without salt and at salt concen-
trations above 200 mM. The highest degree of assembly is
between 50 and 100 mM KCl. In contrast, the DDD-myosin
variant has little ¢lament assembly capacity at any salt con-
centration between 0 and 200 mM [6]. To characterize the in
vitro assembly properties of the di¡erent myosin heavy chain
variants, in each case, the isolated protein was diluted with
bu¡ers to obtain di¡erent salt concentrations. The samples
were centrifuged to separate the soluble and precipitated frac-
tions and the amount of soluble protein was determined in a
Bradford assay. Fig. 5 shows solubility curves of the myosin
heavy chain variants. The highest degree of assembly for wt-
myosin was observed in the 50^100 mM ranges. This as well
as the inability of DDD-myosin to form ¢laments is consistent
with previously published solubility data for both proteins
[6,24]. The TTD-myosin variant had the same ¢lament assem-
bly properties as wt-myosin (Fig. 5). All myosin variants con-
taining an aspartate at position 1833 and either a threonine or
an alanine at position 1823 (TDT-myosin, TDD-myosin and
ADD-myosin) were also able to form ¢laments. The highest
degree of ¢lament formation these variants could obtain was
between 80 and 90% at physiological salt conditions (50 mM
for Dictyostelium [25]). Substitution of threonine 1823 to an
aspartate had a negative impact on ¢lament formation prop-
erties of the myosin. At 50 mM KCl, approximately 30% of
the DTT-myosin stayed soluble. The same solubility behavior
was seen for the DTD-myosin variant. These observations
suggest that a negative charge in position 2029 has no signi¢-
cant e¡ect on the ¢lament formation properties of the protein.
In contrast, changing threonine residues 1823 and 1833 in the
myosin heavy chain to aspartate increased the solubility of the
myosin at all salt concentrations to more than 80% as seen for
the DDT-myosin and DDD-myosin in Fig. 5. These data
strongly suggest a dominant role of position 1823 on the
¢lament formation of myosin. If this residue cannot get de-
phosphorylated, myosin stays in monomeric form to a large
extent. In order to rule out phosphorylation of the unmuta-
genized threonine residues in the myosin variants after puri¢-
cation of the protein, we treated samples with alkaline phos-
phatase. Heavy chain phosphate, but not light chain
phosphate, is removed by treatment with bacterial alkaline
phosphatase [24]. The salt curves of the alkaline phospha-
Fig. 4. Developmental phenotypes of Dictyostelium cells expressing
di¡erent myosin heavy chain variants. Myosin null cells were trans-
formed with pLittleDTT, pLittleDDT, pLittleDTD, pLittleTDD,
pLittleTTD, pLittleTDT, pLittleADD as well as pLittleMyo and
pBigAsp and plated on Klebsiella lawns. The di¡erent myosin var-
iants are indicated.
Fig. 5. Salt-dependence of ¢lament formation of wt-myosin and its
variants. Puri¢ed proteins were dialyzed into bu¡er without salt.
Filament formation was induced by adding KCl in various concen-
trations and the mixture was incubated for 15 min on ice. Filaments
were sedimented by centrifugation. The amount of soluble myosin
was determined in a Bradford assay. DTD-myosin (R), DDT-myo-
sin (F), DTT-myosin (S), TDD-myosin (E), TTD-myosin (P),
TDT-myosin (O), ADD-myosin (7), wt-myosin (a) and DDD-my-
osin (b).
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tase-treated proteins were identical to the untreated samples
(data not shown).
4. Discussion
The in vivo results reported here lead to the somewhat
surprising conclusion that the nature of the amino acid at
positions 1833 and 2029 in Dictyostelium myosin has little
in£uence on the ability of cells to divide in suspension. The
residue at position 1823 critically determines the regulation of
myosin thick ¢lament formation and in vivo function. The
comparison of cells expressing di¡erent myosin variants in
respect to development provides a similar picture.
From the in vivo results, we conclude that the amino acid
at position 1823 has to be able to get dephosphorylated dur-
ing the life cycle of the cell. However, it is not necessary that
this residue allows phosphorylation to sustain growth in sus-
pension or development as seen in the ADD-myosin variant.
These data are in accordance with previously published results
on a AAA variant [6]. Cells expressing AAA-myosin were able
to grow in suspension and formed fruiting bodies on bacterial
lawns. The in vivo data suggest that positions 1833 and 2029
do not have strong in£uence on cell growth and sporulation.
On the other hand, the in vitro ¢lament assembly measure-
ment unveiled ¢ner e¡ects by position 1833 that were not
obvious from the in vivo assays. From this assay, the puri¢ed
myosin variants were further characterized to determine the
in£uence of each single threonine-aspartate substitution,
which mimics a phosphorylation event, on the ability to
form ¢laments. As described earlier [6], the introduction of
three aspartate residues completely blocks ¢lament formation.
The same result was obtained by introducing two negative
charges at positions 1823 and 1833 (DDT). However, two
negative charges are not su⁄cient to disrupt ¢lament forma-
tion if introduced in positions 1833 and 2029 (TDD) as seen
in the TDD-myosin and ADD-myosin variants, both of which
show ¢lament assembly curves similar to wt-myosin. How-
ever, myosin with a threonine at position 1833 recovers the
ability to form thick ¢lament even when position 1823 con-
tains an aspartate residue. As seen in Fig. 5, DTT and DTD
form thick ¢laments better than DDT.
The mechanism for Dictyostelium myosin ¢lament assembly
is thought to proceed in two stages. The initial slower step
occurs by sequential association of myosin II monomers into
parallel dimers and antiparallel tetramers. The next step is
rapid lateral addition of myosin dimers to bipolar nuclei to
form thick ¢laments [27]. Previous to the initial step, myosin
monomers are thought to equilibrate between the folded and
straight conformations. This is based on a study showing that
a folded conformation of the myosin molecule is promoted by
phosphorylation of the heavy chain by Dictyostelium myosin
heavy chain kinase, and the folded monomers are excluded
from ¢laments formed upon addition of salt [26]. As already
seen for the in vivo data shown above, position 1823 is most
critical for the ability of myosin to form ¢laments. By chang-
ing threonine at position 1823 to aspartate, myosin ¢lament
formation is dramatically a¡ected via two possible ways. The
¢rst way is by shifting the equilibrium between the folded and
the straight conformations previous to the initial step of ¢la-
ment assembly. A negative charge at position 1823 probably
favors the folded monomers and therefore reduces the avail-
able straight monomers to form dimers. Dimers are the pre-
requisite to tetramers and the following thick ¢lament assem-
bly. A genetic screen to search for suppressors of the 3UAsp
cells also leads to a complete recovery of wt function by
changing the aspartate at position 1823 to a tyrosine [28].
This result further supports the proposal that missing the
negative charge at this position results in a preference of the
straight conformation and therefore favors ¢lament assembly.
The second way that position 1823 could contribute is at
the initial slower step where myosin monomers assemble into
parallel dimers and antiparallel tetramers. The region of the
myosin tail that interacts in the parallel dimer has been
mapped previously using rotary shadowing electron micros-
copy [26]. Although D1823 lies outside of the region of con-
tact common to all parallel dimers, it is the closest of the three
phosphorylation sites to the assembly domain. Furthermore,
all three residues are within the ¢nal 42 nm of the tail, which
is the region that overlaps in the antiparallel tetramers [26]. A
study using monoclonal antibodies is consistent with the im-
portance of the end of the tail in antiparallel interactions.
Only small parallel aggregates form in the presence of a
monoclonal antibody against Dictyostelium myosin that binds
at the carboxy-terminus of the tail [29]. Therefore, it is rea-
sonable that the T1823D change a¡ects both the parallel di-
merization and the following antiparallel tetramerization. The
interaction between two monomers in a myosin ¢lament ap-
pears to be along more than half of the myosin tail [26]. It is
surprising therefore that the introduction of a single charge
has such a dramatic e¡ect on this interaction. Two analogous
cases are described in which a single charge change disrupts
¢lament assembly. One is paramyosin in Caenorhabditis ele-
gans [30] and another is the R1880P mutation in Dictyostelium
myosin [23]. Recent work provided evidence that, besides
charge-charge interactions, hydrophobic interactions are likely
to play a major role in myosin ¢lament assembly [31]. The
disruption of dimer formation due to introduction of a neg-
ative charge in a hydrophobic interaction core is a common
phenomenon. An example for the disruption of dimer forma-
tion by changing one hydrophobic amino acid for a negatively
charged amino acid was described for the elongation factor Ts
from Thermus thermophilus [32].
What is the structural basis for the inhibition of ¢lament
formation based on phosphorylation? The tail of the myosin
heavy chain contains a 7 residue repeat, characteristic of K-
helical coiled-coil proteins in which the ¢rst and fourth amino
acids are highly hydrophobic [8]. This pattern allows the for-
mation of an internal hydrophobic core of the coil. Whereas
T1833 and T2029 lie adjacent to but not within the hydro-
phobic core [10], T1823 is located at a core position [11].
Moreover, T1823 lies within a stretch of amino acids where
11 out of 23 residues are positively charged. Two negatively
charged regions surround this positively charged region. A
proposed mechanism of ¢lament formation would be the
charge-charge interaction of the positive stretch of amino
acids to the negative stretch along another myosin molecule
[11]. Phosphorylation of T1823 introduces a negative charge
into the hydrophobic core of the coiled-coil. The result could
disturb the K-helical coiled-coil structure, leading to a confor-
mational change of the myosin rod. Our results show that the
phosphorylation of T1823 is the key for the regulation of
myosin thick ¢lament assembly in vitro and in vivo.
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